Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
neurodegenerative diseases. An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s
-
, infections, and neurodegenerative diseases. An independent organisation, its founding partners are the Medical Research Council, Cancer Research UK, Wellcome, UCL, Imperial College London and King’s College
-
organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London. The Crick was formed
-
the Department of Chemical Engineering at Imperial College London (South Kensington Campus). Informal enquiries about the post can be made to Professor Jason Hallett ([email protected] ) and Dr Talia A
-
, UCL (University College London), Imperial College London and King’s College London. The Crick was formed in 2015, and in 2016 it moved into a new state-of-the-art building in central London which brings
-
Technological University (NTU) and Imperial College London. A/Prof Yap laboratory is working on the field of regenerative cardiology and metabolic disorders, where the team is interested in the basic and
-
Inference” theme within the Probabilistic Programming Pillar. This theme will be directed by Will Pearse (Imperial College London), Seth Flaxman (University of Oxford) and Juliette Unwin (University
-
College London), Imperial College London and King’s College London. The Crick was formed in 2015, and in 2016 it moved into a new state-of-the-art building in central London which brings together 1500
-
researchers from Bath, Newcastle, Edinburgh, Manchester, Imperial College London and Queen Mary. Having started in 2022, our team now includes about 40 researchers across the UK with growing links between
-
About the role The project is part of an interdisciplinary, collaborative and international project involving groups in Imperial College London, the Netherlands Cancer Institute (NKI) Amsterdam